We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.31%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$23B
AUM Growth
-$233M
(-1%)
Cap. Flow
-$880M
Cap. Flow
% of AUM
-3.82%
Top 10 Holdings %
Top 10 Hldgs %
33.31%
Holding
1,606
New
44
Increased
614
Reduced
449
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$63.2M |
| 2 |
Eagle Materials
EXP
|
+$56.2M |
| 3 |
Itron
ITRI
|
+$54.4M |
| 4 |
Apple
AAPL
|
+$52.6M |
| 5 |
Enphase Energy
ENPH
|
+$40.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cooper Companies
COO
|
+$82.8M |
| 2 |
NVIDIA
NVDA
|
+$76M |
| 3 |
Microsoft
MSFT
|
+$62.6M |
| 4 |
Adobe
ADBE
|
+$62.2M |
| 5 |
Jabil
JBL
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.79% |
| 2 | Healthcare | 19.28% |
| 3 | Financials | 10.14% |
| 4 | Communication Services | 9.05% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TPH
951
DELISTED
Tri Pointe Homes
TPH
| $773K | ﹤0.01% |
20,755
| – | – |
|
952
Atkore
ATKR
$3.17B
| $769K | ﹤0.01% |
5,700
| – | – |
|
953
Credo Technology Group
CRDO
$49.6B
| $767K | ﹤0.01% |
24,000
+6,600
| +38% | +$146K |
|
954
Carrier Global
CARR
$52.2B
| $761K | ﹤0.01% |
12,065
-529,185
| -98% | -$32.5M |
|
955
Copa Holdings
CPA
$6.17B
| $761K | ﹤0.01% |
8,000
| – | – |
|
|
GMS
956
DELISTED
GMS Inc
GMS
| $761K | ﹤0.01% |
9,437
| – | – |
|
|
ESGR
957
DELISTED
Enstar Group
ESGR
| $760K | ﹤0.01% |
2,486
+300
| +14% | +$90K |
|
958
Yeti Holdings
YETI
$3.44B
| $759K | ﹤0.01% |
19,900
+1,100
| +6% | +$42.8K |
|
959
Apple Hospitality REIT
APLE
$3.75B
| $758K | ﹤0.01% |
52,118
| – | – |
|
960
ACV Auctions
ACVA
$1.35B
| $757K | ﹤0.01% |
41,500
+16,200
| +64% | +$291K |
|
961
Silicon Laboratories
SLAB
$7.28B
| $756K | ﹤0.01% |
6,837
| – | – |
|
962
Travel + Leisure Co
TNL
$4.58B
| $756K | ﹤0.01% |
16,800
-8,600
| -34% | -$386K |
|
|
CERE
963
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $756K | ﹤0.01% |
18,500
+2,300
| +14% | +$95.8K |
|
964
Sabra Healthcare REIT
SBRA
$5.15B
| $755K | ﹤0.01% |
49,006
+900
| +2% | +$12.9K |
|
965
TriNet
TNET
$3.22B
| $754K | ﹤0.01% |
7,537
-2,700
| -26% | -$301K |
|
|
FOLD
966
DELISTED
Amicus Therapeutics
FOLD
| $753K | ﹤0.01% |
75,941
+21,900
| +41% | +$225K |
|
967
UMB Financial
UMBF
$11.5B
| $753K | ﹤0.01% |
9,030
-900
| -9% | -$73.8K |
|
968
Perrigo
PRGO
$1.78B
| $750K | ﹤0.01% |
29,200
| – | – |
|
|
UCTT
969
Ultra Clean Holdings
UCTT
$4.21B
| $750K | ﹤0.01% |
15,300
-3,600
| -19% | -$162K |
|
970
Broadstone Net Lease
BNL
$4.35B
| $749K | ﹤0.01% |
47,200
+17,300
| +58% | +$262K |
|
971
California Water Service
CWT
$3.1B
| $749K | ﹤0.01% |
15,454
+2,058
| +15% | +$100K |
|
972
Lazard
LAZ
$4.43B
| $748K | ﹤0.01% |
19,600
| – | – |
|
973
Matsons
MATX
$6.39B
| $747K | ﹤0.01% |
5,700
-300
| -5% | -$34.9K |
|
|
SWTX
974
DELISTED
SpringWorks Therapeutics
SWTX
| $746K | ﹤0.01% |
19,800
+2,400
| +14% | +$101K |
|
975
Cousins Properties
CUZ
$4.93B
| $744K | ﹤0.01% |
32,120
| – | – |
|
Similar funds
GAM
Handelsbanken Fonder's Q2 2024 Portfolio in Review
As of Q2 2024, Handelsbanken Fonder held 1,606 positions worth $23B, down 1% from $23.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder withdrew a net $880M in Q2 2024, closing 86 positions and reducing 449 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $20.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Handelsbanken Fonder opened a new position in Kenvue worth $12.8M.
- Handelsbanken Fonder's largest Q2 2024 buy was Kenvue: 701,911 shares worth $12.8M.
- Handelsbanken Fonder added most to Vertex Pharmaceuticals in Q2 2024, an estimated $63.2M increase.
- Handelsbanken Fonder's biggest Q2 2024 reduction was Cooper Companies, cutting an estimated $82.8M.
- Handelsbanken Fonder fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $20.6M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $23B portfolio in Q2 2024.
- Handelsbanken Fonder opened 44 new positions and closed 86 in Q2 2024.
- Handelsbanken Fonder's portfolio value fell 1% quarter-over-quarter to $23B.
Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.